Ricardo Blanco Selected Research

penicillin N (isopenicillin N)

1/2014

Urticarial vasculitis in northern Spain: clinical study of 21 cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ricardo Blanco Research Topics

Disease

40	Rheumatoid Arthritis 05/2022 - 10/2007
30	Inflammation (Inflammations) 01/2021 - 10/2007
25	Uveitis 01/2022 - 08/2012
23	Ankylosing Spondylitis 06/2021 - 11/2012
21	Vasculitis (Vasculitides) 05/2022 - 01/2011
20	Giant Cell Arteritis (Horton Disease) 05/2022 - 08/2004
14	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2022 - 05/2013
13	Atherosclerosis 10/2022 - 01/2012
10	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2022 - 01/2018
10	Insulin Resistance 06/2021 - 11/2012
10	Cardiovascular Diseases (Cardiovascular Disease) 05/2019 - 12/2011
9	Psoriatic Arthritis 04/2022 - 11/2014
9	Infections 04/2022 - 03/2014
8	Hidradenitis Suppurativa 10/2022 - 05/2009
8	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2020 - 11/2014
6	Anemia 04/2022 - 05/2011
6	Axial Spondyloarthritis 01/2022 - 01/2018
6	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 02/2019 - 08/2004
6	Purpura 03/2018 - 05/2014
5	Autoimmune Diseases (Autoimmune Disease) 04/2022 - 06/2012
5	Anterior Uveitis 01/2022 - 01/2013
5	Behcet Syndrome (Behcet's Syndrome) 01/2021 - 04/2015
5	Macular Edema 01/2019 - 01/2013
5	Necrosis 01/2019 - 02/2013
4	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022 - 01/2014
4	Neoplasms (Cancer) 04/2022 - 08/2012
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2020 - 06/2012
4	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2018 - 01/2015
4	Pain (Aches) 01/2017 - 01/2012
4	Sarcoidosis (Schaumann Disease) 12/2015 - 10/2006
3	Obesity 05/2022 - 08/2020
3	Herpes Zoster 04/2022 - 10/2017
3	Systemic Scleroderma (Systemic Sclerosis) 03/2022 - 06/2012
3	Connective Tissue Diseases (Connective Tissue Disease) 03/2022 - 07/2020
3	Takayasu Arteritis (Arteritis, Takayasu's) 01/2021 - 08/2015
3	Dyslipidemias (Dyslipidemia) 08/2020 - 08/2012
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 07/2018 - 01/2013
3	Melanoma (Melanoma, Malignant) 03/2018 - 08/2012
3	Fever (Fevers) 05/2016 - 06/2014
3	Leukocytosis (Pleocytosis) 11/2014 - 01/2014
2	Fibrosis (Cirrhosis) 04/2022 - 07/2021
2	Nasopharyngitis 04/2022 - 02/2013
2	Posterior Uveitis 01/2022 - 01/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 12/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2012
22	tocilizumab (atlizumab)FDA Link 01/2022 - 03/2011
16	Adalimumab (Humira)FDA Link 04/2022 - 05/2009
14	Infliximab (Remicade)FDA Link 01/2021 - 05/2009
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2019 - 05/2009
12	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 07/2009
11	C-Reactive ProteinIBA 10/2021 - 06/2014
11	Pharmaceutical PreparationsIBA 01/2019 - 08/2012
10	AdipokinesIBA 05/2022 - 11/2013
10	Biological ProductsIBA 04/2022 - 05/2014
10	secukinumabIBA 06/2021 - 01/2017
9	OsteoprotegerinIBA 10/2022 - 01/2014
9	Immunoglobulin A (IgA)IBA 08/2021 - 03/2014
7	Monoclonal AntibodiesIBA 06/2021 - 11/2012
7	Methotrexate (Mexate)FDA LinkGeneric 05/2021 - 03/2011
6	CytokinesIBA 03/2022 - 04/2015
5	AdiponectinIBA 05/2022 - 05/2013
5	Janus Kinase InhibitorsIBA 04/2022 - 02/2013
5	Interleukin-6 (Interleukin 6)IBA 03/2022 - 12/2011
5	Prednisone (Sone)FDA LinkGeneric 01/2022 - 08/2012
5	HLA-DRB1 Chains (HLA DRB1)IBA 10/2020 - 08/2004
4	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2022 - 09/2013
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2007
4	upadacitinibIBA 04/2022 - 10/2020
4	tofacitinibIBA 01/2022 - 02/2013
4	Abatacept (Orencia)FDA Link 12/2021 - 01/2018
4	InterleukinsIBA 06/2021 - 01/2011
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 12/2014
4	LeptinIBA 11/2020 - 07/2013
4	golimumab FDA Link 07/2018 - 01/2014
4	Etanercept (Enbrel)FDA Link 02/2014 - 10/2006
3	Angiopoietin-2IBA 10/2022 - 07/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 01/2017
3	Antirheumatic Agents (DMARD)IBA 04/2022 - 01/2017
3	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2012
3	ApelinIBA 06/2021 - 07/2013
3	HLA-B Antigens (HLA-B)IBA 03/2021 - 04/2015
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 04/2015
3	Interleukin-33IBA 01/2021 - 01/2014
3	LipidsIBA 08/2020 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2020 - 04/2015
3	GlucocorticoidsIBA 01/2020 - 01/2018
3	Azathioprine (Imuran)FDA LinkGeneric 01/2019 - 07/2015
3	Antinuclear AntibodiesIBA 01/2017 - 01/2014
3	Anti-Citrullinated Protein AntibodiesIBA 01/2014 - 01/2012
2	Ligases (Synthetase)IBA 03/2022 - 07/2020
2	Antimalarials (Antimalarial Agents)IBA 01/2022 - 01/2020
2	N 30IBA 01/2022 - 09/2020
2	Methylprednisolone FDA LinkGeneric 01/2022 - 01/2016
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2022
2	CalciumIBA 01/2022 - 01/2018
2	baricitinibIBA 01/2022 - 01/2017
2	Janus KinasesIBA 10/2021 - 10/2020

Therapy/Procedure

53	Therapeutics 05/2022 - 10/2006
9	Biological Therapy 01/2021 - 02/2014